Kein Unternehmensprofil gefunden.
Aktuelle News
News Funktionen
Weitere Funktionen
7 September 2021
13:01
Corporate
EN
Tarus Therapeutics
Corporate
EN
Dr. John Stagg, a world-leader in the adenosine pathway, joins Scientific Advisory Board of Tarus Therapeutics, Inc.
27 Mai 2021
13:00
Corporate
EN
Tarus Therapeutics
Corporate
EN
Tarus Therapeutics receives clearance from the FDA to initiate clinical trial of TT-4 (A2BR antagonist) in cancer patients
28 April 2021
13:00
Corporate
EN
Tarus Therapeutics
Corporate
EN
Tarus Therapeutics seeks to initiate clinical trial of TT-4 (A2BR antagonist) in cancer patients
6 April 2021
13:01
Corporate
EN
Tarus Therapeutics
Corporate
EN
Tarus Therapeutics receives clearance from the FDA to initiate clinical trial of TT-10 (A2AR antagonist) in cancer patients
10 März 2021
14:03
Corporate
EN
Tarus Therapeutics
Corporate
EN
Tarus Therapeutics seeks to initiate clinical trial of TT-10 (A2AR antagonist) in cancer patients
2 Dezember 2020
13:00
Corporate
EN
Tarus Therapeutics
Corporate
EN
Tarus Therapeutics Strengthens its Board of Directors with Appointment of Paolo Pucci
Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()